1. The structure–antituberculosis activity relationships study in a series of 5-aryl-2-thio-1,3,4-oxadiazole derivatives
- Author
-
Nathaly Shvets, Athina Geronikaki, Anatholy Dimoglo, Robert C. Reynolds, Serghei Pogrebnoi, Fliur Macaev, Veaceslav Boldescu, Zinaida Ribkovskaia, and Ghenadie Rusu
- Subjects
Models, Molecular ,Oxadiazoles ,Stereochemistry ,Aryl ,Organic Chemistry ,Clinical Biochemistry ,Antitubercular Agents ,Molecular Conformation ,Pharmaceutical Science ,Thio ,Mycobacterium tuberculosis ,Biochemistry ,Structure-Activity Relationship ,chemistry.chemical_compound ,chemistry ,Catalytic Domain ,Drug Discovery ,Mycobacterium tuberculosis H37Rv ,Humans ,Molecular Medicine ,Molecule ,1 3 4 oxadiazole derivatives ,Molecular Biology - Abstract
A series of 82 5-aryl-2-thio-1,3,4-oxadiazole derivatives were screened for their anti-mycobacterial activities against Mycobacterium tuberculosis H37Rv. The synthesized compounds 30–37 appeared to be the most active derivatives exhibiting more than 90% inhibition of mycobacterial growth at 12.5 μg/mL. Structure–activity relationships study was performed for the given series by using the electronic-topological method combined with neural networks (ETM–NN). A system for the anti-mycobacterial activity prediction was developed as the result of training associative neural network (ASNN) with weights calculated from projections of a compound and each pharmacophoric fragment found on the elements of the Kohonen’s self-organizing maps (SOMs). From the detailed analysis of all compounds under study, the necessary requirements for a compound to possess antituberculosis activity have been formulated. The analysis has shown that any requirement’s violation for a molecule implies a considerable decrease or even complete loss of its activity. Molecular docking studies of the compounds allowed shedding light on the binding mode of these novel anti-mycobacterial inhibitors.
- Published
- 2011
- Full Text
- View/download PDF